Home / Pharma Healthcare / Global Human Vaccine Market Research Report 2019

Global Human Vaccine Market Research Report 2019

  • Id : RNR-264417
  • Category : Pharma Healthcare
  • Publish Date : Mar-19
  • Publisher : Research-N-Reports
  • Pages : 123
  • Format : PDF
License Type

Description
A vaccine is a biological preparation that provides active acquired immunity to a particular disease. A vaccine typically contains an agent that resembles a disease-causing microorganism and is often made from weakened or killed forms of the microbe, its toxins or one of its surface proteins. The agent stimulates the body's immune system to recognize the agent as a threat, destroy it, and keep a record of it so that the immune system can more easily recognize and destroy any of these microorganisms that it later encounters. Vaccines can be prophylactic (example: to prevent or ameliorate the effects of a future infection by any natural or "wild" pathogen), or therapeutic (e.g., vaccines against cancer are being investigated).
The average price of China Human Vaccine is in the increasing trend, from 4.14 USD/Dose in 2013 to 4.49 USD/Dose in 2017. With the situation of global economy, prices will be in increasing trend in the following five years.
The classification of China Human Vaccine includes Varicella, Influenza, Polio, Hepatitis A, Rabies, BCG, Hepatitis B, Pertussis, Diphtheria, Tetanus, Pneumococcal, Rota vaccine and other kinds of vaccines, and the proportion of Rabies in 2017 is about 20.4%, and the proportion is in fluctuation trend from 2013 to 2017.

The global Human Vaccine market is valued at 14100 million US$ in 2018 is expected to reach 30600 million US$ by the end of 2025, growing at a CAGR of 10.2% during 2019-2025.
This report focuses on Human Vaccine volume and value at global level, regional level and company level. From a global perspective, this report represents overall Human Vaccine market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan.
At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered in this report.

The following manufacturers are covered:
CNBG
Changsheng Life
Zhifei
ChengDa Bio
Kangtai
SINOVAC BIOTECH
Hissen
Walvax Biotechnology
GSK
SANOFI
Rong An
NuoCheng Bio
Hualan Bio
Tiantan biological
Changchun Baike
Adimmune
Zhongyianke Biotech

Segment by Regions
North America
Europe
China
Japan

Segment by Type
Varicella
Influenza
Polio
Hepatitis A
Rabies
BCG
Hepatitis B
Pertussis, Diphtheria, Tetanus
Pneumococcal
Rota vaccine

Segment by Application
Adults
Children